FHR-3, Human, mAb clone 3.11
This monoclonal is unique, since it is not cross reactive with any of the seven proteins that belong to the Factor H (FH)-protein family.
Read more
Anti-FHR-3; clone 3.11 is a mouse monoclonal antibody recognizing human full length Complement Factor H-related protein 3 (FHR-3), a glycoprotein that belongs to the complement regulatory protein family. FHR-3 is synthesized and secreted primarily by the liver but also by immune cells such as monocytes, macrophages, and dendritic cells. It is present in plasma in various glycosylated forms ranging from 35 to 56 kDa. Structurally, FHR-3 shares homology with Complement Factor H (CFH), a pivotal regulator within the complement system. Also FHR-3 operates as part of the complement regulatory network, contributing to control of the complement cascade but its precise function is poorly characterized. FHR-3 predominantly exerts its regulatory influence within the alternative pathway (AP) of the complement system. Weak cofactor activity and an enhancement of the FH cofactor activity were reported, and also a marginal inhibitory effect was observed in hemolytic assays using FH depleted serum. However, these results need to be confirmed in independent studies. Disruptions in FHR-3 expression or function have been linked to specific diseases. For instance, imbalances in FHR-3 levels or activities have been associated with conditions like atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration (AMD) and systemic lupus erythematosus (SLE). In these disorders, aberrant complement activation and deposition on self-tissues can contribute to pathological processes. FHR-3’s involvement in the alternative pathway positions it as a potential therapeutic target for interventions aimed at modulating complement-driven diseases. The participation of FHR-3 in the AP suggests its potential as a therapeutic target for interventions aimed at controlling diseases driven by complement dysregulation.
You may also like…
You may be interested in…
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA